FDA Inspection 897817 — Resilience US, Inc.

Resilience US, Inc. — FEI 1000305672

The FDA completed an inspection of Resilience US, Inc. on Sep 25, 2014 in Allston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 25, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allston, MA (United States)

Citations

IDCFRDescription
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.